Enclosed is our assessment of the Food and Drug Administration's compliance with the procedural steps required by sections 801(a)(1)(B)(i) through (iv) of title 5 with respect to the rule.
Our findings have found that the FDA's sections 801(a)(1)(B)(i) through (iv) of title 5 do not exist.